SCHEMBL19764489

SCHEMBL19764489

CCOc1ncc(C(=O)N(C)OC)s1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.40
DYRK1A Q13627 1/20 0.40
DYRK1B Q9Y463 1/20 0.40
ICAM1 P05362 1/20 0.36
SELE P16581 1/20 0.36
TRPM8 Q7Z2W7 2/20 0.34
CDC7 O00311 1/20 0.34
DBF4 Q9UBU7 1/20 0.34
ACACB O00763 2/20 0.34
CYP2C9 P11712 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16935072 0.83 HDAC4 (0.38) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL15575294 0.78 CLK1 (0.43) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL22021995 0.78 HCAR2 (0.55) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL19764487 0.78 CDC7 (0.43) CDC7DBF4ACACBCYP2C9SMN1; SMN2
SCHEMBL9643722 0.77 HCAR2 (0.53) CDC7DBF4SMN1; SMN2ALDH1A1HPGD
SCHEMBL10183970 0.76 CLK1 (0.42) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL17747762 0.74 FAAH (0.40) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL20487461 0.73 CLK1 (0.40) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL23039876 0.72 CLK1 (0.39) CLK1DYRK1ADYRK1BICAM1SELE
SCHEMBL2073998 0.71 NPC1 (0.58) TRPM8CDC7DBF4CYP2C9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180009796-A1 ISOQUINOLINE DERIVATIVES AS MGAT2 INHIBITORS MERCK SHARP & DOHME LLC 2018-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180009796-A1 ISOQUINOLINE DERIVATIVES AS MGAT2 INHIBITORS MGAT2, MGAT1, ACAT2 CLK1 3466/4885DYRK1A 4573/4885DYRK1B 4634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.